Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ending drug trial secrecy is a boon for R&D, says EU agency
Yahoo/Reuters
Monday, October 21, 2013 - 5:49pm
tags:
clinical trial data, R&D
Is Amarin Going Belly-Up?
Seeking Alpha
Monday, October 21, 2013 - 4:16pm
tags:
Amarin, FDA, Vascepa
OncoMed presents data from trials of four anti-CSC therapeutics
The Fly on the Wall
Monday, October 21, 2013 - 4:14pm
tags:
OncoMed, anti-CSC
3 Red Flags for This Biotech IPO
Motley Fool
Monday, October 21, 2013 - 4:13pm
tags:
Intrexon, IPOs
Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Fierce Biotech
Monday, October 21, 2013 - 11:55am
tags:
John Lechleiter, R&D, Eli Lilly
Earnings for C.R. Bard Expected to Fall
Forbes
Monday, October 21, 2013 - 11:54am
tags:
CR Bard, earnings, devices
Anticipated Earnings Increase for Bristol-Myers Squibb
Forbes
Monday, October 21, 2013 - 11:52am
tags:
Bristol-Myers Squibb, earnings
Can Eli Lilly Earnings Keep Up With Merck and Pfizer?
Motley Fool
Monday, October 21, 2013 - 11:52am
tags:
Eli Lilly, earnings, Merck, Pfizer
Catalyst Pharmaceuticals And Their Business Plan
Seeking Alpha
Monday, October 21, 2013 - 11:51am
tags:
Catalyst Pharmaceutical Partners, Biomarin, Biogen Idec, Firdapse, Lambert-Eaton myasthenic syndrome
Medtronic launches Export Advance catheter in the U.S.
Mass Device
Monday, October 21, 2013 - 10:08am
tags:
Medtronic, devices, Export Advance, aspiration catheter
VC funding follows tepid pace in Q3 as first-time biotech rounds shrivel
Fierce Biotech
Monday, October 21, 2013 - 10:06am
tags:
venture capital, biotech
GSK/Genmab file Arzerra for first-line CLL
Pharma Times, UK
Monday, October 21, 2013 - 9:56am
tags:
Arzerra, GSK, Genmab, CLL, chronic lymphocytic leukemia
Bristol-Myers Researcher Falsified Data In Grants And PhD Thesis
Pharmalot
Monday, October 21, 2013 - 9:55am
tags:
Bristol-Myers Squibb, R&D
Universities Stepping Up Efforts To Discover Drugs
Forbes
Monday, October 21, 2013 - 9:32am
tags:
R&D, Eli Lilly, Academic Drug Discovery Consortium, ADDC
TherapeuticsMD Still Attractive Despite Run Up ... HRT Market Wide Open
Seeking Alpha
Monday, October 21, 2013 - 9:28am
tags:
HRT, TherapeuticsMD
StemCells announces results of long-term follow-up study in Batten disease
Yahoo/Fly on the Wall
Monday, October 21, 2013 - 9:17am
tags:
StemCells, stem cells, Batten disease, HuCNS-SC cells
Osiris and FDA Reach Agreement on Regulatory Pathway for Biosurgery Products
Yahoo
Monday, October 21, 2013 - 9:16am
tags:
FDA, Osiris Therapeutics, Grafix, Ovation, biosurgery
Regeneron's Eylea improves vision in another eye disorder
Reuters
Monday, October 21, 2013 - 8:40am
tags:
Regeneron, Eylea
GW Pharma cannabis drug gets green light in France
Reuters
Monday, October 21, 2013 - 8:39am
tags:
GW Pharma, cannabis, France, Sativex, MS, multiple sclerosis
Can Amgen Grow Faster Than Gilead Sciences and Teva Pharmaceutical?
Motley Fool
Monday, October 21, 2013 - 8:37am
tags:
Gilead, Teva, Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.